HOME > COMMENTARY
COMMENTARY
-
How Will Industry Counter Proposed Re-Pricing of “Huge Seller” Drugs?
August 18, 2015
-
Leaner Sales Forces? Lower Profits? Drug Makers Face Tough Decision in 80% Generic Era
August 14, 2015
-
PMDA Poised to Tap Big Data to Refine Reviews, Safety Steps; Dedicated Center Eyed in 2018
August 12, 2015
-
Wholesalers Face Pressing Need to Retool Biz Strategy as Generics Gain Ground
July 21, 2015
-
Viable Third-Party Review System Required for Drug Makers’ Advertisements
July 7, 2015
-
Japan Compassionate Use System a “Stick” for Drug Makers? Incentives to Counter Their Burden Needed
June 22, 2015
-
Generic Makers Baffled by New Govt Target, Quality and Supply Concerns Linger
June 15, 2015
-
Thorny Path Ahead toward Trial Rollout of Cost-Effective Assessment in FY2016; Chuikyo to Begin Discussions on May 27
May 26, 2015
-
1 Year after Viagra Generic Debut, Freely Priced Generics Seem to Be Bringing Benefits
May 8, 2015
-
Opdivo Offers Hope but Poses Challenges Too, Cautious Approach Needed to Expand Indications
April 27, 2015
-
Will Japanese Drug Makers Become More Discerning in Unearthing Seeds?
April 17, 2015
-
Patient Subsidy System Expanded for Intractable Diseases, What about Incentives for Drug Makers?
April 7, 2015
-
Abe Pledges Biosimilar Promotion, but Doctor Misconception and Lack of Incentives Remain as Challenges
March 30, 2015
-
SGLT-2 Inhibitor Sales Would Plunge If Used Only in Younger, Obese Patients, but Cautious Administration Warranted
March 17, 2015
-
Uncertainty Swirling around Possible Drug Price Cuts for 3 Straight Years
March 16, 2015
-
Drug Repositioning May Promise Greater Chance of Success, but Problems Remain
March 6, 2015
-
As Adjuvant Development Race Heats Up, New Databases Could Turn Japan into Global Vaccine Powerhouse
February 16, 2015
-
Japan Poised to Tap Its Version of “Compassionate Use” to Combat Challenges Left for Unapproved Drugs
February 2, 2015
-
Open Innovation Bandwagon Gathers Pace for Efficient Drug Discovery
January 26, 2015
-
Have AGs Finally Become a Good Option to Counter Generics?
January 19, 2015
ページ
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…
